Abstract
Ventriculoperitoneal (VP) shunts are commonly used in neurosurgical procedures to treat hydrocephalus. Although shunt-associated abdominal complications are well documented, extrahepatic pseudocysts are a rare shunt complication in adult patients. Therefore, we herein report the case of a 54-year-old male patient who presented with a bulging mass around the previous surgical site at the right upper quadrant of the abdomen. He had a 4-year history of VP shunt surgery for posthemorrhagic hydrocephalus. A computed tomographic scan revealed a large extrahepatic pseudocsyt. Our case represented a rare entity of extrahepatic pseudocyst in adult patients underwent VP shunt surgery. The clinical presentation, diagnostic tools, and treatment methods were discussed.
Ventriculoperitoneal (VP) shunts are commonly used in neurosurgical procedures to divert excess cerebrospinal fluid (CSF) from the ventricular system into the abdominal cavity, which is indicated for hydrocephalus related to congenital hydrocephalus, trauma, hemorrhage, neoplasms, infection, and various other conditions.1 Several abdominal complications are common in patients undergoing VP shunts, including pseudocysts, infection, and hollow organ perforation.2, 3 Catheter migrations may occur into the abdominal cavity including abdominal wall, small bowel, large bowel, gall bladder, liver, stomach, vagina, fallopian tube, urinary bladder, or scrotum.4-6 Abdominal pseudocysts occur in less than 10% of all patients receiving VP shunts and occur primarily in pediatric populations.7
Hepatic pseudocyst secondary to shunt operation is a rare entity, which is classified as intra-axial and extra-axial types.8 The intra-axial hepatic pseudocysts commonly demonstrate that the tip of the shunt can be dislodged into the liver parenchyma.9 By penetrating the Glisson’s capsule, the distal tube cause subcapsular pseudocyst formation in patients with extra-axial hepatic pseudocysts.3 However, extrahepatic pseudocysts are rare shunt complications in adult patients, and only several cases have been reported in the relevant literature.10-15 Therefore, we herein report the development of extrahepatic pseudocysts following VP shunt surgery in a 54-year-old male patient. The clinical presentation, diagnostic tools, and treatment methods are also discussed to manage this rare complication.
Case Report
Patient information
This case report was approved by the Institutional Review Board of Chia-Yi Christian Hospital in Taiwan (No.IRB2020064). The timeline for this case report was summarized in Table 1. A 54-year-old male patient had a 4-year history of spontaneous intracerebral hemorrhage at the left basal ganglion with ventricular extension. Initially, the external ventricular device (EVD) was inserted. However, the intracranial pressures were persistently high and VP shunt surgery with medium pressure reservoir implantation (Medtronic, USA) was placed because of posthemorrhagic hydrocephalus. This VP shunt surgery was placed via open mini-laparatomy without a trocar and the peritoneal tube was placed freely in the peritoneum. Four years after the placement, he started to develop a progressive bulging mass around the previous surgical site at the right upper quadrant of the abdomen 2 weeks before admission.
Clinical findings
At admission, he was alert and orientated. His blood temperature was 36.3°C. Physical examination revealed a soft, bulging mass around the previous surgical wound at the right upper quadrant of the abdominal wall, measuring approximately 3 cm × 3 cm. There was no any redness around the distal shunt tube or pseudomeningocele around the valve. The reservoir function of the VP shunt was intact. Laboratory examination of peripheral blood revealed a white blood cell count of 5570/μL and a C-reactive protein level of 0.34 mg/μL.
Diagnostic assessment
The computed tomographic (CT) scan of brain revealed brain atrophy, large encephalomalacia at left basal ganglion, and mild hydrocephalus (Figure 1). Abdominal radiography showed a loop of the peritoneal tube around the right upper quadrant of the abdomen (Figure 2). The subsequent CT scan of the abdomen indicated a small cyst-like lesion, measuring approximately 3.6 cm × 2 cm × 3.5 cm, which was found at the right anterior abdominal wall along the abdominal entry point of the shunt (Figure 3A). A large cystic lesion at the right extrahepatic region was also discovered, containing the peritoneal tube of the VP shunt (Figure 3B and C). The intraabdominal cystic lesion was found to measure approximately 16 cm × 11 cm × 16.5 cm.
Therapeutic intervention
Because of the impression of the shunt-associated extrahepatic pseudocyst, the patient underwent distal externalization of the VP shunt and laparoscopic surgery to remove the cystic lesion. At operation, the laparoscopic view showed that a huge cystic lesion with a thin wall contained mildly turbid fluid and was approximately 16 cm in diameter. One fistula tract existed from the cystic wall to the abdominal wall. Surgical unroofing of the cystic lesion was performed (Figure 4). A microscopic view of this cystic lesion showed a dense thick fibrous wall and chronic granulomatous inflammation of histiocytes, lymphocytes, and plasma cells along the internal capsule (Figure 5). Outside the fibrous capsule, there was a small rim of atrophic liver tissue.Pathological examination confirmed the pseudocyst diagnosis.
Follow-up and outcomes
Postoperatively, the patient was afebrile. Flomoxef with a dose of 1gm every 8 hours was prescribed because of the externalized VP shunt. The total protein and glucose of CSF sampled from the externalized shunt were 31.2 mg/μL and 62 mg/μL, respectively. The color of CSF was clear. No bacterial growth was found in a series of CSF cultures. A weaning trial from the VP shunt was successfully performed 7 days after surgery. Finally, the distal shunt was ligated at the right anterior chest region. We removed the externalized distal end and leaved proximal end in place. The patient remained alert and orientated at the 2-month follow-up. No abdominal discomforts were complained.
Discussion
Hydrocephalus is a common neurosurgical entity, and the peritoneal cavity is the most reliable and commonly used place for receipt of excess CSF from the ventricular system.1 Common VP shunt-associated abdominal complications include distal catheter migration, abscesses, peritonitis, CSF ascites, inguinal hernia, shunt malfunction caused by excessive intraperitoneal tube length, or pseudocysts.4,5 Abdominal pseudocysts, first reported by Harsh in 1954,16 are a rare VP shunt-associated complication. The incidence of abdominal pseudocysts has been estimated to be approximately 0.25-10%, and pediatric patients comprise the majority of cases.7,8 However, adult cases of shunt-associated extrahepatic pseudocysts have rarely been described, and only a few cases have been reported in the relevant literature.10-15
Although the etiology of abdominal pseudocysts remains unclear, the inflammatory process is the most likely cause.8,11 Several predisposing factors have been discovered, including (1) revision of shunt procedures, (2) peritoneal adhesion due to previous abdominal surgery, (3) malabsorption of CSF, (4) allergy to silicone or ethylene oxide, (5) an increase in the CSF protein content, or (6) intracranial tumors.7,8,17 Extra-axial type of hepatic pseudocysts may be caused by peritoneal tube’s direct penetration or migration into Glisson’s capsule, causing focal liver surface injury and further chronic irritation.11 In our case, the prior peritoneal shunt was placed through the use of the mini-open laparotomy method. No direct injury of Glisson’s capsule was detected. No symptoms were noted for more than 4 years, and all CSF cultures were sterile during this admission. Otherwise, the histological features of the cystic lesion in our case demonstrated the invasion of lymphocytes, indicating an inflammatory reaction.17 Therefore, focal inflammation secondary to the migration of the peritoneal tube into Glisson’s capsule may have contributed to the formation of extrahepatic pseudocysts in our patient.
Although the typical presentation of hepatic pseudocysts is poorly defined, several symptoms such as abdominal pain, abdominal distention, local tenderness around the abdominal entry site of the shunt, or abdominal masses should be considered as indicators of pseudocysts.18 Neurological complaints related to hepatic pseudocysts may be infrequent because the CSF absorption initially decreases, but the dose not cease entirely.8 Otherwise, a 17%–80% infection rate has been reported for abdominal pseudocysts, and Staphylococcus aureus and S. epidermidis are the most commonly detected bacteria.19 However, the infection incidence is lower in adults (15%) than in children (33%).7 Furthermore, smaller abdominal pseudocysts tend to be infected, and larger pseudocysts tend to be sterile.2 Although CSF studied in the reported cases of extrahepatic pseudocysts in adults has been mostly sterile,10,12-14 CSF culture should nonetheless be performed for the prevention of severe intraabdominal infection before revision of the shunt.
Mesenteric cysts, omental cysts, duplication cysts, lymphoceles, cystic teratomas, cystic lymphangiomas, pancreatic pseudocysts, abscesses, and bilomas should be included for the various diagnoses of abdominal pseudocysts.14 Ultrasonography has been introduced for easy diagnosis of pseudocsyts, which typically demonstrate a well-defined sonolucent mass with posterior acoustic enhancement.2 The shunt tip within the pseudocyst can also be identified. However, CT scans are considered to be more reliable and valuable for investigating abdominal pseudocysts. Most extrahepatic pseudocysts are characterized as parenchyma-free capsule formations with smooth margins extending outward from the liver and isodense cyst content with CSF. Nuclear medicine can also be used to evaluate shunt patency.20 The loculation of a radioactive tracer within the abdominal collection suggests pseudocyst formation after the injection of radioisotopes into the shunt reservoir.2
Some treatment algorithms have been described for the management of abdominal pseudocysts.21,22 The shunt tap is the most vital step in the confirmation of further treatment requirements. If infection is initially eliminated, distal catheter repositioning is the only suitable method for the treatment of patients with sterile abdominal pseudocysts.4 If infection is suspected or the status is unknown, distal tube externalization followed by appropriate antibiotic treatment is recommended.8, 21 Furthermore, laparotomy with adhesion lysis, abdominal pseudocyst aspiration, or shunt removal can potentially be performed depending on the complexity of shunt-associated intraabdominal complications. If the CSF is sterile, the peritoneal cavity, pleural space, atrium, or gallbladder can be used to reposition the distal catheter for patients who remain shunt-dependent.22 Reaccumulation of pseudocysts remains a challenge for pediatric patients with abdominal pseudocysts who have undergone fluid drainage followed by the externalization or revision of shunts.1 In a literature review of adult cases with hepatic pseudocysts, Dabdoub et al observed no recurrences after the revision of the shunt, even in cases of infection.8 Our patient presented with a typical large hepatic pseudocyst containing sterile CSF. However, our patient required no further revision of the shunt following distal tube externalization after the successful weaning test. Based on the reported cases with hepatic pseudocysts, the treatment algorithm is simply summarized in Figure 6.
In conclusion, adult extrahepatic pseudocysts are a rare shunt complication. Abdominal pseudocysts should be considered in VP shunt patients with abdominal complaints. Early diagnosis and surgical intervention are the keystones to the management of this rare complication.
Supplements
* Supplements will be considered for work including proceedings of conferences or subject matter covering an important topic
* Material can be in the form of original work or abstracts.
* Material in supplements will be for the purpose of teaching rather than research.
* The Guest Editor will ensure that the financial cost of production of the supplement is covered.
* Supplements will be distributed with the regular issue of the journal but further copies can be ordered upon request.
* Material will be made available on Saudi Medical Journal website
Footnotes
Disclosure. The authors declare no conflicting interests, support or funding from any drug company.
- Received July 16, 2020.
- Accepted August 30, 2020.
- Copyright: © Neurosciences
Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.